Overview

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The primary goal of the research is to determine if 10 days of dual anti-platelet treatment is as effective as 30 days of similar treatment in the prevention of stroke, myocardial ischemia (MI) and death in patients with TIAs and minor stroke.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alberta
Treatments:
Aspirin
Clopidogrel
Ticlopidine